All Business articles
View all stories with this category.
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
Business
Rosa Biotech gets biosensors on the nose
Protein barrel arrays mimic mammals’ olfactory system to distinguish many different molecules
-
Business
Russian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
Business
Drop in plasma donations hits immunoglobulin supply
Lockdown and social distancing have discouraged donors, and the potential impact of convalescent plasma collection for Covid-19 treatment is unclear
-
Business
Uncovering the sources of contaminated sanitisers
Methanol and 1-propanol could get into hand gels by unintentional or deliberate adulteration
-
Opinion
Facing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
Opinion
From collaboration to collusion
The US government’s crackdown on academics not declaring Chinese funding highlights a moral hazard
-
Business
Overcoming hydrogen hype
European strategies set up hydrogen’s potential contribution to lowering carbon emissions
-
Business
Russian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
Business
Encouraging signs from initial Covid-19 vaccine trials
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible
-
Business
Questions surround deadly Beirut blast
Ammonium nitrate explosion that killed at least 135 appears to have been caused by poorly-stored cargo from an abandoned vessel
-
Business
Deadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
Business
Dow to cut 2000 jobs worldwide
Cuts prompted by slowdown in high value construction and automotive materials
-
-
Business
Appeals court cuts damages further in glyphosate cancer case
Judgment retains verdict that Bayer-Monsanto’s herbicide caused US man’s cancer
-
Opinion
Looking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
Business
Reducing food waste by touch
Mimica’s tactile food labels know better than best-before dates
-
Business
What are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
Business
Ineos to buy BP petrochemicals businesses for $5bn
Deal covers 14 acetyls and aromatics manufacturing plants and 10 joint ventures
-
Business
Bayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
